The new member of IKCC’s Medical Advisory Board, Shankar Siva, shared an important update on radiation oncology: SBRT for primary renal cell carcinoma. #KidneyCancer @myESMO (3/3)

IKCC had the pleasure to listen to the high-level presentation of its Board Chair, Dr Eric Jonasch, on HIF-2 alpha inhibitors, as part of the MSD symposium on the management of clear cell renal cell carcinoma. (2/3)

The IKCC team is fully mobilised for #ESMOAsia25 in Singapore. Dr Munisamy Murallitharan shared the results from the IKCC global patient survey on “knowledge gaps and disparities in kidney cancer across Asia”, during a session chaired by Ravindran Kanesvaran. (1/3)

(ESMO) has published a patient guide on immune-related side effects and their management. This will help families affected by kidney cancer better understand immunotherapy-related side effects and management. To find out more: https://t.co/iVA0MtR6cY

#KidneyCancer treatment often includes drug therapies like targeted therapies, immunotherapies, or combinations of the two. Each option works differently and may be used at different stages of the disease. Explore clear, reliable information about treatment options at our

Congratulations to Prof Ravindran Kanesvaran, member of the IKCC Medical Advisory Board, for organising such a high-level event. (2/2)

Today in Singapore, IKCC was honoured to join the APAC Oncology Summit on Genitourinary Cancer, focusing on “Bridging the Molecular Testing Gap to Drive Better Outcomes”. (1/2)

We are looking forward to #ESMOAsia25 this week in Singapore. Eric Jonasch, Anne Wilson and Olivier Exertier will represent IKCC at this event with oncology experts from across the Asia-Pacific region.

Active surveillance is a treatment approach used when small kidney tumors can be safely monitored instead of removed right away. It involves regular imaging and check-ins with your care team to track any changes over time. Learn more about when active surveillance is used and

Singapore is really advancing “Integrative Oncology,” combining Western Medicine and Evidence-Based Traditional Chinese Medicine to treat patients holistically. (2/2)

On Tuesday, IKCC visited the National Cancer Centre Singapore with Prof Ravindran Kanesvaran and Kwang Cheak Tan, CEO of the Singapore Cancer Society. (1/2)

🤝 In collaboration with @MayoClinic, join us for a virtual education event for patients and families facing #kidneycancer! @BradLeibovichMD @ZakhariaYousef 🔗 Register - https://t.co/Usm5HdGV33

Uniting voices for transforming cancer care. The World Leaders Summit, themed “Bridging Divides, Building Futures,” focused on closing global gaps in cancer care. #FutureOfCancerCare #StrongerTogether #BridgingDivides #CancerEquity #UnitingForCancerCare #SpreadingHope

THE DEADLINE IS FAST APPROACHING! SEND YOUR APPLICATION IN ASAP! The Anil Kapoor Research Grant is accepting applications until December 15th 2025! Don't miss this opportunity! 💚 Apply here: https://t.co/8BctZwPe44 or on our website! @CanUrolAssoc

Research across Europe is improving precision medicine through molecular characterisation and targeted diagnostics. How will this become part of routine cancer care? Hear from researchers from Spain to Sweden on 4 December:  https://t.co/RcNPCBysg6 #MissionCancer #EUMissions

Kudos to @F_Sordelli for her great work on this systematic review & meta-analysis on the #oncological outcomes of #treated and #untreated Complex #cystic Renal Masses published in @EurUrolFocus ! 👏🫂 A wonderful collaboration between @EAUYAU_RenalCa & @RoyalFreeNHS team

On Tuesday, IKCC met in Melbourne with Telix to discuss priorities and collaborations related to #KidneyCancer in 2026. Thank you to Simone Leyden for welcoming us at their headquarters. @TelixPharma

Join us 12/3 @ 1 PM ET! Our resource-focused webinar series dives into all the free programs + support available to you after a #kidneycancer diagnosis. 🧡 ✨ Don’t miss the chance to hear directly from the experts and advocates behind these resources: https://t.co/oYURc6RA3c

Leadership Changes in the @IKCCorg Board of Directors @EJonasch @Claudia_Ung @advocatekidneys https://t.co/5iGIBK1tIp #Cancer #Medicine #Health #Oncology #OncoDaily #IKCC #KidneyCancer #MedX #MedNews #MedEd

We welcome the opportunity to work with leaders across Europe to ensure that patient needs, evidence and lived experience remain central to policy and practice. #EuropeanCancerSummit2025 #PatientAdvocacy #KidneyCancer (2/2)